Back to Main

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 03, 2013

By: NASDAQ.com News
Posted: 5/31/2013 9:00:00 AM
Referenced Stocks: AMGN;DES;EES;GILD;PDLI

PDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on June 03, 2013. A cash dividend payment of $0.15 per share is scheduled to be paid on June 12, 2013. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 12th quarter that PDLI has paid the same dividend. At the current stock price of $8.39, the dividend yield is 7.15%.

The previous trading day's last sale of PDLI was $8.39, representing a -1% decrease from the 52 week high of $8.48 and a 35.76% increase over the 52 week low of $6.18.

PDLI is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Amgen Inc. ( AMGN ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.54. Zacks Investment Research reports PDLI's forecasted earnings growth in 2013 as 17.46%, compared to an industry average of 6.3%.

For more information on the declaration, record and payment dates, visit the PDLI Dividend History page.

Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:

The top-performing ETF of this group is EES with an increase of 14.23% over the last 100 days. DES has the highest percent weighting of PDLI at 0.85%.